Women with type 2 diabetes more likely to develop mental health issues than men

Publicly released:
International
CC-0
CC-0

Following a type 2 diabetes diagnosis, women are more likely than men to develop mental health conditions, while men are more likely to develop heart and kidney problems, according to UK scientists. The team looked at health records of nearly 30,000 British people with type 2 diabetes and found that, in the years following diagnosis, women were more likely to develop mental health conditions, including trajectories resulting in death, while men were more likely to develop heart and kidney disease and high blood pressure. The findings highlight the need for healthcare interventions tailored by characteristics such as sex and age, the authors conclude.

News release

From: PLOS

Women with type 2 diabetes are more likely than men to develop mental health conditions

Men, on the other hand, experience more cardiovascular and renal disease post-diagnosis

In the years following type 2 diabetes diagnosis, women are more likely to develop mental health conditions, while men are more likely to develop cardiovascular and renal complications, according to a study published August 25th in the open access journal PLOS Medicine by Fabiola Eto from Queen Mary University of London, UK, and colleagues.

Type 2 diabetes, a metabolic disorder defined by high blood sugar, results from resistance to or insufficient production of insulin. Globally, type 2 diabetes affects about 536.6 million people between 20 and 79 years old, or 10.5% of the population; by 2045, this number is expected to rise to 700 million. Cardiovascular disease, end-stage renal disease, and mental health disorders like depression and anxiety are all associated with type 2 diabetes. Women and men are known to experience these conditions differently, but research has not yet described the disease trajectories according to sex and age in people with type 2 diabetes.

Eto and colleagues examined anonymized health records from 28,720 men and women in the UK who developed type 2 diabetes between 2010 and 2020. Men constituted 62% of the cohort with a median age of 54 at type 2 diabetes onset; women were on average older at diagnosis.

In the years following diagnosis, 39% of the participants experienced at least one significant health event. The events’ trajectory and timing differed by sex. For example: women were more likely to develop mental health conditions post-diagnosis (8.1% compared to 5.3%) and to experience trajectories culminating in death, while men showed higher proportions of cardiovascular disease (8.4% compared to 5.3%), end-stage renal disease, and hypertension (21.1% compared to 20.2%). The researchers noted that on average, women used more health services and long-term prescriptions than men, which may contribute to the increased diagnoses.

There were several similarities between the sexes as well. Both women and men who had a combination of type 2 diabetes and a mental health condition experienced premature mortality compared to other trajectories. Across all age groups and sexes, hypertension was the most frequent event following type 2 diabetes.

Current UK medical guidelines lack sex-specific prevention strategies and management for type 2 diabetes and comorbidities, especially mental health conditions. This study highlights the need for healthcare interventions differentiated by characteristics like sex and age.

The authors add, “One of the clearest signals in our data was the sex difference. Younger women with type 2 diabetes were showing mental health complications earlier and more often than we expected, which suggests routine psychological screening should be incorporated into standard diabetes care. For men, the pattern looked different: cardiovascular and kidney risks tended to emerge earlier, pointing to a need for earlier monitoring and stronger strategies to support men's engagement with their treatment over time.”

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research PLOS, Web page The URL will go live after the embargo ends
Journal/
conference:
PLOS Medicine
Research:Paper
Organisation/s: Queen Mary University of London, UK
Funder: This work (and salary costs to SF, RM, and FE) was supported by MRC (MR/S027297/1). “Multimorbidity clusters, trajectories and genetic risk in British south Asians, 2020-2023”. Link: https://gtr.ukri.org/projects?ref=MR%2FS027297%2F1. Additional support for this and related work (SF, MRB, RH, AA, MS, DS, and FE) is from NIHR 31672 AI-MULTIPLY, 2022-2025, and NIHR 202635 (SF, MRB). MRB is also funded by NIHR Newcastle Patient Safety Research Collaborative (NIHR204291). RM is also supported by Barts Charity (MGU0504).
Media Contact/s
Contact details are only visible to registered journalists.